clinical trial · NCT06081166
A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin
NewAmsterdam Pharma·phase1·completed·n = 74
Healthy VolunteersObicetrapibAtorvastatin CalciumRosuvastatin Calcium
brief summary
A study to evaluate impact of Obicetrapib on PK levels of Atorvastatin and Rosuvastatin
started
Nov 11, 2023
primary completion
Dec 2, 2023
completion
Jan 22, 2024
last updated
May 22, 2025
detailed description
A Study to Evaluate the Effect of Daily Doses of Obicetrapib Tablets on the Pharmacokinetics of Atorvastatin Calcium Tablets or Rosuvastatin Calcium Tablets in Healthy Adult Subjects
official title
A Study to Evaluate the Effect of Daily Doses of Obicetrapib Tablets on the Pharmacokinetics of Atorvastatin Calcium Tablets or Rosuvastatin Calcium Tablets in Healthy Adult Subjects
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol